63 results
Page 3 of 4
8-K
EX-99.1
x42p38lx
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
S-3
EX-1.2
pvpg01
4 Oct 19
Shelf registration
4:06pm
DEF 14A
rsnyfzmo 8hh
26 Apr 19
Definitive proxy
12:00am
DEFA14A
e1rteyrn
26 Apr 19
Additional proxy soliciting materials
12:00am
10-K
EX-3.2
utbw4 pllbgeo4rtl
1 Apr 19
Annual report
12:00am
10-K
6cidef
1 Apr 19
Annual report
12:00am
10-Q
EX-3.2
qyvx o2sq
14 Nov 18
Quarterly report
12:00am
10-Q
0evt nh1id
14 Nov 18
Quarterly report
12:00am
DRS/A
lyfq85pnp92znvn
10 Jul 18
Draft registration statement (amended)
12:00am
DRS
EX-10.9
qspagchc qflk2
1 Jun 18
Draft registration statement
12:00am
DRS
EX-10.2
awayikiq06pk63r4okjz
1 Jun 18
Draft registration statement
12:00am
DRS
EX-10.3
o9ec mp8dt
1 Jun 18
Draft registration statement
12:00am
DRS
EX-4.3
fwe1t6ortv9fuug8 0d
1 Jun 18
Draft registration statement
12:00am